title: Response to the Letter: "Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man".
authors.affiliation: Oxford Centre for Diabetes, Endocrinology, and Metabolism, National Institute for Health Research, Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford OX3 7LE, United Kingdom.
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Hazlehurst
authors.affiliation: Oxford Centre for Diabetes, Endocrinology, and Metabolism, National Institute for Health Research, Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford OX3 7LE, United Kingdom.
authors.forename: Jeremy W
authors.initials: JW
authors.lastname: Tomlinson
mesh_terms: D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase; D058891:5-alpha Reductase Inhibitors; D001378:Azasteroids; D042944:Cholestenone 5 alpha-Reductase; D006801:Humans; D008055:Lipids; D008297:Male
chemical_list: D058891:5-alpha Reductase Inhibitors; D001378:Azasteroids; D008055:Lipids; D042944:Cholestenone 5 alpha-Reductase; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase